The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology

Journal of the Neurological Sciences

Volumn 348, Issue 1-2, 2015, Pages 126-131

  Tettey, Prudence ^a   Simpson, Steve ^a   Taylor, Bruce V ^a   Van Der Mei, Ingrid A F ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Autoimmune; Comorbidity; Latitudinal gradient; Multiple sclerosis; Type 1 diabetes; Ultraviolet radiation and vitamin D

Indexed keywords

HLA ANTIGEN; LEUKOCYTE ANTIGEN; VITAMIN D;

ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE CO-OCCURRENCE; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HAPLOTYPE; HEREDITY; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS (TOPIC); MULTIPLE SCLEROSIS; NEUROPATHOLOGY; PATHOGENESIS; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW (TOPIC); T LYMPHOCYTE; DIABETES MELLITUS, TYPE 1; GENETICS;

COMORBIDITY; DIABETES MELLITUS, TYPE 1; HUMANS; MULTIPLE SCLEROSIS;

EID: 84920973686     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.11.019     Document Type: Article

References (90)

1. A.S. Matheus, L.R. Tannus, R.A. Cobas, C.C. Palma, C.A. Negrato, and Mde B. Gomes Impact of diabetes on cardiovascular disease: an update Int J Hypertens 2013 2013 653789
2. G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, and C.J. Paciorek National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 2011 31 40
3. Economic costs of diabetes in the U.S. in 2012 Diabetes Care 36 2013 1033 1046
4. A. Compston, and A. Coles Multiple sclerosis Lancet 359 2002 1221 1231
5. S. Tesfaye, and D. Selvarajah Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy Diabetes Metab Res Rev 28 Suppl. 1 2012 8 14
6. S. Winer, I. Astsaturov, R. Cheung, L. Gunaratnam, V. Kubiak, and M.A. Cortez Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis J Immunol 166 2001 2831 2841
7. A.M. Courtney, K. Treadaway, G. Remington, and E. Frohman Multiple sclerosis Med Clin North Am 93 2009 ix x
8. M.A. Atkinson, and G.S. Eisenbarth Type 1 diabetes: new perspectives on disease pathogenesis and treatment Lancet 358 2001 221 229
9. N.M. Nielsen, T. Westergaard, M. Frisch, K. Rostgaard, J. Wohlfahrt, and N. Koch-Henriksen Type 1 diabetes and multiple sclerosis: a Danish population-based cohort study Arch Neurol 63 2006 1001 1004
10. S. Bechtold, A. Blaschek, K. Raile, A. Dost, C. Freiberg, and M. Askenas Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetes population: analysis from DPV data base Diabetes Care 37 1 2014 96 101
11. A.L. Ponsonby, R.M. Lucas, and I.A. van der Mei UVR, vitamin D and three autoimmune diseases - multiple sclerosis, type 1 diabetes, rheumatoid arthritis Photochem Photobiol 81 2005 1267 1275
12. M.G. Marrosu, E. Cocco, M. Lai, G. Spinicci, M.P. Pischedda, and P. Contu Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study Lancet 359 2002 1461 1465
13. O. Frongia, F. Mastinu, and G.M. Sechi Prevalence and 4-year incidence of insulin-dependent diabetes mellitus in the province of Oristano (Sardinia, Italy) Acta Diabetol 34 1997 199 205
14. J.S. Dorman, A.R. Steenkiste, J.P. Burke, and M. Songini Type 1 diabetes and multiple sclerosis: together at last Diabetes Care 26 2003 3192 3193
15. E. Wertman, N. Zilber, and O. Abramsky An association between multiple sclerosis and type I diabetes mellitus J Neurol 239 1992 43 45
16. W.I. Hussein, and S.S. Reddy Prevalence of diabetes in patients with multiple sclerosis Diabetes Care 29 2006 1984 1985
17. R. Dobson, and G. Giovannoni Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis J Neurol 260 2013 1272 1285
18. K.F. Tait, T. Marshall, J. Berman, J. Carr-Smith, B. Rowe, and J.A. Todd Clustering of autoimmune disease in parents of siblings from the type 1 diabetes Warren repository Diabet Med 21 2004 358 362
19. R.D. Henderson, C.J. Bain, and M.P. Pender The occurrence of autoimmune diseases in patients with multiple sclerosis and their families J Clin Neurosci 7 2000 434 437
20. R.A. Marrie, R. Rudick, R. Horwitz, G. Cutter, T. Tyry, and D. Campagnolo Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis Neurology 74 2010 1041 1047
21. N. Koch-Henriksen, and P.S. Sorensen The changing demographic pattern of multiple sclerosis epidemiology Lancet Neurol 9 2010 520 532
22. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999 Diabet Med 23 2006 857 866
23. S.A. Warren, L.W. Svenson, and K.G. Warren Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada Mult Scler 14 2008 872 879
24. M. Pugliatti, T. Riise, M.A. Sotgiu, S. Sotgiu, W.M. Satta, and L. Mannu Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia Neuroepidemiology 25 2005 129 134
25. M. Debouverie, S. Pittion-Vouyovitch, S. Louis, T. Roederer, and F. Guillemin Increasing incidence of multiple sclerosis among women in Lorraine, eastern France Mult Scler 13 2007 962 967
26. M.A. Kramer, N.A. van der Maas, E.M. van Soest, J.M. Kemmeren, H.E. de Melker, and M.C. Sturkenboom Incidence of multiple sclerosis in the general population in the Netherlands, 1996-2008 Neuroepidemiology 39 2012 96 102
27. M.H. Barnett, D.B. Williams, S. Day, P. Macaskill, and J.G. McLeod Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study J Neurol Sci 213 2003 1 6
28. H. Houzen, M. Niino, D. Hata, F. Nakano, S. Kikuchi, and T. Fukazawa Increasing prevalence and incidence of multiple sclerosis in northern Japan Mult Scler 14 2008 887 892
29. O. Krokki, R. Bloigu, M. Reunanen, and A.M. Remes Increasing incidence of multiple sclerosis in women in northern Finland Mult Scler 17 2011 133 138
30. R. Midgard, T. Riise, C. Svanes, G. Kvale, and H. Nyland Incidence of multiple sclerosis in More and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis Brain 119 Pt 1 1996 203 211
31. N. Grytten, S.B. Glad, J.H. Aarseth, H. Nyland, R. Midgard, and K.M. Myhr A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway Neurology 66 2006 182 186
32. L.M. Grimaldi, B. Palmeri, G. Salemi, G. Giglia, M. D'Amelio, and R. Grimaldi High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy Neuroepidemiology 28 2007 28 32
33. A. Alonso, and M.A. Hernan Temporal trends in the incidence of multiple sclerosis: a systematic review Neurology 71 2008 129 135
34. Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group Lancet 355 2000 873 876
35. W.H. Lin, M.C. Wang, W.M. Wang, D.C. Yang, C.F. Lam, and J.N. Roan Incidence of and mortality from type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study PLoS One 9 2014 e86172
36. V. Harjutsalo, L. Sjoberg, and J. Tuomilehto Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study Lancet 371 2008 1777 1782
37. K. Vehik, R.F. Hamman, D. Lezotte, J.M. Norris, G. Klingensmith, and C. Bloch Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth Diabetes Care 30 2007 503 509
38. P. Barat, A. Valade, P. Brosselin, C. Alberti, S. Maurice-Tison, and C. Levy-Marchal The growing incidence of type 1 diabetes in children: the 17-year French experience in Aquitaine Diabetes Metab 34 2008 601 605
39. E.A. Gale, and K.M. Gillespie Diabetes and gender Diabetologia 44 2001 3 15
40. P.E. Wandell, and A.C. Carlsson Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden Curr Diabetes Rev 9 2013 342 349
41. A. Laroni, M. Calabrese, P. Perini, M.P. Albergoni, F. Ranzato, and M. Tiberio Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in north-east Italy J Neurol 253 2006 636 639
42. H.W. Baker, J.I. Balla, H.G. Burger, P. Ebeling, and I.R. Mackay Multiple sclerosis and autoimmune diseases Aust N Z J Med 2 1972 256 260
43. E. Belniak, Z. Stelmasiak, and E. Papuc Multiple sclerosis and other autoimmune diseases Neurol Neurochir Pol 41 2007 259 266
44. A. Lernmark Multiple sclerosis and type 1 diabetes: an unlikely alliance Lancet 359 2002 1450 1451
45. R. Buzzetti, P. Pozzilli, U. Di Mario, C. Ballerini, and L. Massacesi Multiple sclerosis and type I diabetes Diabetologia 45 2002 1735 1736
46. The expanding genetic overlap between multiple sclerosis and type I diabetes Genes Immun 10 2009 11 14
47. F. Weber, B. Fontaine, I. Cournu-Rebeix, A. Kroner, M. Knop, and S. Lutz IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations Genes Immun 9 2008 259 263
48. H.Q. Qu, A. Montpetit, B. Ge, T.J. Hudson, and C. Polychronakos Toward further mapping of the association between the IL2RA locus and type 1 diabetes Diabetes 56 2007 1174 1176
49. S. Romagnani Biology of human TH1 and TH2 cells J Clin Immunol 15 1995 121 129
50. G.F. Cahill Jr., and H.O. McDevitt Insulin-dependent diabetes mellitus: the initial lesion N Engl J Med 304 1981 1454 1465
51. M. Knip, M. Kukko, P. Kulmala, R. Veijola, O. Simell, and H.K. Akerblom Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes Am J Med Genet 115 2002 48 54
52. C.S. Raine, B. Cannella, S.L. Hauser, and C.P. Genain Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation Ann Neurol 46 1999 144 160
53. A. Minagar, W. Jy, J.J. Jimenez, and J.S. Alexander Multiple sclerosis as a vascular disease Neurol Res 28 2006 230 235
54. A. Minagar, and J.S. Alexander Blood-brain barrier disruption in multiple sclerosis Mult Scler 9 2003 540 549
55. W.Y. Almawi, H. Tamim, and S.T. Azar Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes J Clin Endocrinol Metab 84 1999 1497 1502
56. A. Rabinovitch, and W.L. Suarez-Pinzon Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus Biochem Pharmacol 55 1998 1139 1149
57. C. Fozza, M. Zoledzieska, M. Pitzalis, M.P. Simula, A. Galleu, and S. Contini TCRBV20S1 polymorphism does not influence the susceptibility to type 1 diabetes and multiple sclerosis in the Sardinian population Immunogenetics 64 2012 153 154
58. S. Simpson Jr., L. Blizzard, P. Otahal, I. Van der Mei, and B. Taylor Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis J Neurol Neurosurg Psychiatry 82 2011 1132 1141
59. J.A. Staples, A.L. Ponsonby, L.L. Lim, and A.J. McMichael Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence Environ Health Perspect 111 2003 518 523
60. M.A. Hernan, M.J. Olek, and A. Ascherio Geographic variation of MS incidence in two prospective studies of US women Neurology 53 1999 1711 1718
61. H.K. Akerblom, and M. Knip Putative environmental factors in type 1 diabetes Diabetes Metab Rev 14 1998 31 67
62. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis. Part II: noninfectious factors Ann Neurol 61 2007 504 513
63. I.A. van der Mei, A.L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons, and B.V. Taylor Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study BMJ 327 2003 316
64. S.M. Orton, L. Wald, C. Confavreux, S. Vukusic, J.P. Krohn, and S.V. Ramagopalan Association of UV radiation with multiple sclerosis prevalence and sex ratio in France Neurology 76 2011 425 431
65. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838
66. C.S. Zipitis, and A.K. Akobeng Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis Arch Dis Child 93 2008 512 517
67. S.B. Mohr, C.F. Garland, E.D. Gorham, and F.C. Garland The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide Diabetologia 51 2008 1391 1398
68. M.T. Kampman, T. Wilsgaard, and S.I. Mellgren Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle J Neurol 254 2007 471 477
69. S.V. Ramagopalan, A.E. Handel, G. Giovannoni, S. Rutherford Siegel, G.C. Ebers, and G. Chaplin Relationship of UV exposure to prevalence of multiple sclerosis in England Neurology 76 2011 1410 1414
70. R.M. Lucas, A.J. McMichael, B.K. Armstrong, and W.T. Smith Estimating the global disease burden due to ultraviolet radiation exposure Int J Epidemiol 37 2008 654 667
71. S. Simpson Jr., B. Taylor, L. Blizzard, A.L. Ponsonby, F. Pittas, and H. Tremlett Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis Ann Neurol 68 2010 193 203
72. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, and A.L. Belman Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis Ann Neurol 67 2010 618 624
73. K.L. Munger, S.M. Zhang, E. O'Reilly, M.A. Hernan, M.J. Olek, and W.C. Willett Vitamin D intake and incidence of multiple sclerosis Neurology 62 2004 60 65
74. M.T. Kampman, L.H. Steffensen, S.I. Mellgren, and L. Jorgensen Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial Mult Scler 18 2012 1144 1151
75. J.M. Burton, S. Kimball, R. Vieth, A. Bar-Or, H.M. Dosch, and R. Cheung A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis Neurology 74 2010 1852 1859
76. M. Soilu-Hanninen, J. Aivo, B.M. Lindstrom, I. Elovaara, M.L. Sumelahti, and M. Farkkila A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis J Neurol Neurosurg Psychiatry 83 2012 565 571
77. E. Hypponen, E. Laara, A. Reunanen, M.R. Jarvelin, and S.M. Virtanen Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 358 2001 1500 1503
78. A.E. Handel, A.J. Williamson, G. Disanto, R. Dobson, G. Giovannoni, and S.V. Ramagopalan Smoking and multiple sclerosis: an updated meta-analysis PLoS One 6 2011 e16149
79. A. Manouchehrinia, C.R. Tench, J. Maxted, R.H. Bibani, J. Britton, and C.S. Constantinescu Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study Brain 136 2013 2298 2304
80. B. Eliasson Cigarette smoking and diabetes Prog Cardiovasc Dis 45 2003 405 413
81. N. van der Werf, F.G. Kroese, J. Rozing, and J.L. Hillebrands Viral infections as potential triggers of type 1 diabetes Diabetes Metab Res Rev 23 2007 169 183
82. A. Tselis Epstein-Barr virus cause of multiple sclerosis Curr Opin Rheumatol 24 2012 424 428
83. Y.H. Almohmeed, A. Avenell, L. Aucott, and M.A. Vickers Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis PLoS One 8 2013 e61110
84. K.T. Coppieters, T. Boettler, and M. von Herrath Virus infections in type 1 diabetes Cold Spring Harb Perspect Med 2 2012 a007682
85. K. Lauer Diet and multiple sclerosis Neurology 49 1997 S55 S61
86. H.C. Gerstein Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature Diabetes Care 17 1994 13 19
87. C.T. Kodl, and E.R. Seaquist Cognitive dysfunction and diabetes mellitus Endocr Rev 29 2008 494 511
88. A.M. Brands, G.J. Biessels, E.H. de Haan, L.J. Kappelle, and R.P. Kessels The effects of type 1 diabetes on cognitive performance: a meta-analysis Diabetes Care 28 2005 726 735
89. S. Overs, C.M. Hughes, J.K. Haselkorn, and A.P. Turner Modifiable comorbidities and disability in multiple sclerosis Curr Neurol Neurosci Rep 12 2012 610 617
90. J.S. Dorman, A.R. Steenkiste, T.P Foley, E.S. Strotmeyer, J.P. Burke, and L.H. Kuller Menopause in type 1 diabetic women: is it premature? Diabetes 50 2001 1857 1862